Huseyin Naci
TitleCited byYear
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study
H Naci, JPA Ioannidis
Bmj 347, f5577, 2013
5732013
Distribution of road traffic deaths by road user group: a global comparison
H Naci, D Chisholm, TD Baker
Injury prevention 15 (1), 55-59, 2009
3042009
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers
JP Jansen, H Naci
BMC medicine 11 (1), 159, 2013
2722013
Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials
H Naci, J Brugts, T Ades
Circulation: Cardiovascular Quality and Outcomes 6 (4), 390-399, 2013
2622013
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals …
C Davis, H Naci, E Gurpinar, E Poplavska, A Pinto, A Aggarwal
bmj 359, j4530, 2017
2402017
From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management
E Mossialos, E Courtin, H Naci, S Benrimoj, M Bouvy, K Farris, P Noyce, ...
Health policy 119 (5), 628-639, 2015
2042015
Economic burden of multiple sclerosis
H Naci, R Fleurence, J Birt, A Duhig
Pharmacoeconomics 28 (5), 363-379, 2010
1972010
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and …
H Naci, JJ Brugts, R Fleurence, B Tsoi, H Toor, AE Ades
European journal of preventive cardiology 20 (4), 641-657, 2013
1472013
Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study
D Chisholm, H Naci, AA Hyder, NT Tran, M Peden
Bmj 344, e612, 2012
782012
The critical role of observational evidence in comparative effectiveness research
RL Fleurence, H Naci, JP Jansen
Health Affairs 29 (10), 1826-1833, 2010
752010
Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence?
E Mossialos, H Naci, E Courtin
Health policy 111 (2), 135-148, 2013
742013
How good is “evidence” from clinical studies of drug effects and why might such evidence fail in the prediction of the clinical utility of drugs?
H Naci, JPA Ioannidis
Annual review of pharmacology and toxicology 55, 169-189, 2015
622015
Characteristics of preapproval and postapproval studies for drugs granted accelerated approval by the US Food and Drug Administration
H Naci, KR Smalley, AS Kesselheim
Jama 318 (7), 626-636, 2017
582017
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials
H Naci, JJ Brugts, R Fleurence, AE Ades
European journal of preventive cardiology 20 (4), 658-670, 2013
552013
The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature
H Naci, R Fleurence, J Birt, A Duhig
Journal of medical economics 13 (1), 78-89, 2010
552010
Evaluation of Wellness Determinants and Interventions by Citizen Scientists
H Naci, JPA Ioannidis
JAMA 350, h1323, 2015
542015
Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials
H Naci, JJ Brugts, R Fleurence, AE Ades
QJM: An International Journal of Medicine 106 (4), 299-306, 2013
492013
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology
N Jackson, D Atar, M Borentain, G Breithardt, M van Eickels, M Endres, ...
European heart journal 37 (9), 747-754, 2015
482015
Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins
H Naci, S Dias, AE Ades
Bmj 349, g5741, 2014
462014
Evidence of comparative efficacy should have a formal role in European drug approvals
C Sorenson, H Naci, J Cylus, E Mossialos
Bmj 343, d4849, 2011
432011
The system can't perform the operation now. Try again later.
Articles 1–20